AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year

Alvotech, the Icelandic holdout battling AbbVie in court over its Humira biosimilar, has reached an accord with the U.S. pharma giant. With a settlement in place, the companies are putting all patent and trade secret litigation to bed.